Clinical Trials

U.S. States Lead Charge on Genetic Privacy Laws in 2025
Management & Regulatory U.S. States Lead Charge on Genetic Privacy Laws in 2025

The realm of genetic privacy has garnered profound attention from lawmakers in the United States as they confront unfolding challenges related to genetic information security and confidentiality. This year, legislative bodies have demonstrated a proactive stance on addressing pressing issues

Will Ibtrozi Become the New Standard for ROS1-Positive NSCLC?
Management & Regulatory Will Ibtrozi Become the New Standard for ROS1-Positive NSCLC?

Imagine facing the battle against a form of lung cancer so rare that it affects only about 2% of those diagnosed with non-small cell lung cancer (NSCLC). This is the reality for those with ROS1-positive NSCLC, a disease that could soon see transformative change with the approval of Nuvation Bio's

Facial Thermal Imaging AI – A Review
Tech & Innovation Facial Thermal Imaging AI – A Review

The world of healthcare diagnostics is witnessing an exciting transformation through the integration of facial thermal imaging with advanced artificial intelligence (AI). In a realm where precision is paramount, this technology promises a breakthrough by offering a non-invasive, real-time

Revolutionizing Allergy Treatment: Eliminating IgE at the Source
Research & Development Revolutionizing Allergy Treatment: Eliminating IgE at the Source

In recent years, advancements in allergy treatment have shifted towards a comprehensive understanding of immunological components that drive allergic reactions, particularly IgE antibodies. As allergens infiltrate the body, IgE antibodies are produced by white blood cells, instigating a cascade of

AI Revolutionizes Drug Development with NVIDIA and IQVIA Partnership
Management & Regulatory AI Revolutionizes Drug Development with NVIDIA and IQVIA Partnership

The pharmaceutical industry, often characterized by lengthy and costly drug development cycles, is on the brink of a revolutionary shift. A strategic partnership between IQVIA, a leader in clinical research services, and NVIDIA, a cutting-edge technology company renowned for AI innovations,

Can Trust Rebuild Diversity in Clinical Trials?
Research & Development Can Trust Rebuild Diversity in Clinical Trials?

In recent years, the underrepresentation of minority groups in clinical trials has emerged as a critical issue in medical research. Despite various interventions designed to increase participation from these communities, the numbers have not seen significant improvement. The challenge is not rooted

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later